Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32048
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVega, Almudena
dc.contributor.authorAbad, Soraya
dc.contributor.authorMacías, Nicolás
dc.contributor.authorAragoncillo, Inés
dc.contributor.authorSantos, Alba
dc.contributor.authorGalán, Isabel
dc.contributor.authorCedeño, Santiago
dc.contributor.authorManuel López-Gómez, Juan
dc.date.accessioned2019-06-28T16:54:28Z-
dc.date.available2019-06-28T16:54:28Z-
dc.date.issued2017-04
dc.identifier.citationClin Kidney J.2017 Apr;(10)2:170-175
dc.identifier.issn2048-8505
dc.identifier.urihttps://hdl.handle.net/20.500.12530/32048-
dc.description.abstractBackground: Mortality in patients with stages 4 and 5 chronic kidney disease (CKD) is higher than in the general population. Body composition predicts mortality. Our objective was to evaluate the effect of body composition on mortality in patients with stages 4 and 5 non-dialysis CKD. Methods: We performed a prospective study of 356 patients with stages 4 and 5 non-dialysis CKD. At baseline, we recorded general characteristics, history of cardiovascular events, body composition, serum inflammatory markers, nutrition and cardiac biomarkers. Body composition was analysed using bioimpedance spectroscopy. We recorded the lean tissue index (LTI), fat tissue index (FTI) and overhydration (OH). During a median (range) follow-up of 22 (3-49) months, we recorded mortality, cardiovascular events and progress to renal replacement therapy. Results: At baseline, mean (± standard deviation) age was 67 ± 13 years (men 64%; diabetes 36%). Mean body mass index was 28.2 ± 12.8 kg/m2, the FTI was 12.3 ± 5.6 kg/m2, the LTI was 15.7 ± 3.4 kg/m2 and median (interquartile range) OH was 0.6 (-0.4 to 1.5) L. Sixty-four (18%) patients died during follow-up. The univariate Cox analysis showed an association between mortality and age, low LTI, high Charlson comorbidity index, previous cardiovascular events, OH, low albumin and prealbumin levels, and high C-reactive protein levels. Kaplan-Meier analysis revealed higher survival in patients with a higher LTI (log-rank, 9.47; P = 0.002). The multivariate Cox analysis confirmed an association between mortality and low LTI (P = 0.031), previous cardiovascular events (P = 0.003) and high Charlson comorbidity index (P = 0.01). We did not find any association between body composition and cardiovascular events or renal replacement therapy. Conclusions: A low LTI is an independent factor for mortality in patients with stages 4 and 5 CKD.
dc.language.isoeng
dc.rightsopenAccess-
dc.subjectbioimpedance
dc.subjectbody mass index
dc.subjectchronic renal failure
dc.subjectnutrition
dc.subjectsurvival
dc.titleLow lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease.
dc.typeArtículo
dc.identifier.pubmedID28396734
dc.format.volume10
dc.format.page170-175
dc.identifier.journalClinical kidney journal
dc.identifier.doi10.1093/ckj/sfw126
dc.format.number2
dc.identifier.pmcPMC5381238
dc.pubmedtypeJournal Article
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:
File Description SizeFormat 
PMC5381238.pdf432.65 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.